Post-hoc analysis of DWN12088: Comparative analysis between fasting period and adverse event incidences in Healthy subjects

M. Park (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), J. Han (Seoul, Republic of Korea)

Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Session: News in treatment and diagnosis of idiopathic interstitial pneumonia
Session type: E-poster
Number: 470

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Park (Seoul, Republic of Korea), J. Heo (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), J. Han (Seoul, Republic of Korea). Post-hoc analysis of DWN12088: Comparative analysis between fasting period and adverse event incidences in Healthy subjects. 470

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictors of loss of asthma control in the Phase 2a INCONTRO trial: A post-hoc analysis
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020


Efficacy of aclidinium/formoterol: pooled post hoc analysis of patients naïve to COPD maintenance therapy
Source: International Congress 2017 – COPD management
Year: 2017


Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study
Source: ERJ Open Res, 5 (1) 00243-2018; 10.1183/23120541.00243-2018
Year: 2019



Impact of grouping patients by 2017 GOLD strategy assessment criteria: a post hoc analysis of the TONADO and OTEMTO trials
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017


Cluster analysis identifying patients with COPD at high-risk of 2-year mortality: preliminary results.
Source: International Congress 2017 – Assessing the functional status of patients with COPD
Year: 2017



Post-hoc analysis of the effect of montelukast in treating post-RSV-bronchiolitic respiratory symptoms in children
Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma
Year: 2007


Late-breaking abstract: Comparative analysis of cardiopulmonary and clinical responses to six minute walking test and maximal exercising test in obese women
Source: Annual Congress 2011 - Physiological basis of respiratory disease
Year: 2011

Mometasone/ indacaterol/ glycopyrronium demonstrates similar efficacy in men and women: post hoc analysis of IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021


Nintedanib in IPF: post hoc analysis of the Italian FIBRONET observational study
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Improvements in lung function with umeclidinium/vilanterol analysed by reversibility at screening: a post hoc analysis of the EMAX trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


ICS withdrawal and exacerbation risk by GOLD 2017 Report: post hoc analysis of the WISDOM trial
Source: International Congress 2018 – Primary care management of respiratory conditions
Year: 2018




Correlation between clinic and remote FEV1 and FeNO measurements; post hoc analysis of the INCONTRO study
Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden
Year: 2020


Post hoc analysis of a randomised controlled trial: effect of vitamin D supplementation on circulating levels of desmosine in COPD
Source: ERJ Open Res, 6 (4) 00128-2019; 10.1183/23120541.00128-2019
Year: 2020



Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial
Source: Eur Respir J, 52 (2) 1800555; 10.1183/13993003.00555-2018
Year: 2018



Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Late Breaking Abstract - Risk of a severe exacerbation following higher reliever use: post-hoc analysis of SYGMA 1 in mild asthma
Source: International Congress 2018 – Variant forms of asthma
Year: 2018



Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited
Source: Eur Respir J 2008; 32: 17-24
Year: 2008



Statistical cluster analysis on the BTS refractory asthma cohort
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011


Interim results for INSPIRE-CF: A 24-month RCT evaluating effects of weekly supervised exercise in children with CF
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016